Oruka Therapeutics (ORKA) Current Leases (2024 - 2026)
Oruka Therapeutics' quarterly Current Leases came in at $680000.0 in Q1 2026, up 140.28% year-on-year from $283000.0 in Q1 2025, and up 9.85% quarter-over-quarter from $619000.0 in Q4 2025.
Oruka Therapeutics has reported Current Leases for 3 years, with the latest figure at $680000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 140.28% year-over-year to $680000.0; the trailing twelve-month figure through Mar 2026 stood at $680000.0 (up 140.28% YoY), and the FY2025 full-year result was $619000.0, up 190.61% from the prior year.
- Current Leases for Q1 2026 stood at $680000.0, up from $619000.0 in the prior quarter.
- The five-year high for Current Leases was $680000.0 in Q1 2026, with the low at $146000.0 in Q3 2024.
- Average Current Leases over 3 years is $431428.6, with a median of $419000.0 recorded in 2025.
- Year-over-year, Current Leases soared 190.61% in 2025 and surged 140.28% in 2026.
- Tracing ORKA's Current Leases over 3 years: stood at $213000.0 in 2024, then soared by 190.61% to $619000.0 in 2025, then increased by 9.85% to $680000.0 in 2026.
- The last three Current Leases figures came in at $680000.0 (Q1 2026), $619000.0 (Q4 2025), and $419000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - | 680,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 680,000.00 |
| Dec 31, 2025 | 619,000.00 |
| Sep 30, 2025 | 419,000.00 |
| Jun 30, 2025 | 660,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Dec 31, 2024 | 213,000.00 |
| Sep 30, 2024 | 146,000.00 |